22/6 Flashcards
A GRACE score of what indicates coronoary angio?
> 3%
Malnutrition = ?
Unintentional weight loss >10% in the last 3-6mnths
or if have a BMI <20 - weight loss >5% in 3-6months
Explain anion gaps
Allows to identify causes of metabolic acidosis
Calculate by calculating diff between +ve ions (Na+ and K+) and (Cl- and HCO3-)
Raised = increase in -ve ions production
- lactate = shock/sepsis
- ketones = DKA
- salicylate = aspirin OD
Normal = losing HCO3
- diarrhoea
- kidney dysfunction
Describe the ABG that you get with aspirin OD
Resp alkalosis followed by metabolic acidosis
What drugs can have an impact on INR
Inducers (increase the clearance of warfarin = decrease INR)
- SCARS
Smoking
Chronic alcohol intake
Antiepileptics
Rifampicin
St Johns Wort
Inhibitors (decrease the clearance of warfarin = increase INR)
ASS-ZOLES
Antibiotics - ciprofloxacin, erythromycin, isoniazid, clarithomycin
SSRIs
Sodium valporate
-Zoles
Hyperparathyroidism increases the risk of psuedo or normal gout?
Pseudo
Why do they get erectile dysfunction in haemochromatosis?
Iron accumulates in the pituitary and blocks it from producing gonadotrophins
How do you confirm cellultiis?
You don’t - it’s a clinical diagnosis
Look over sickle cell again
How is a vaso-occlusive crisis diagnosed>
Clinical diagnosis
Go over antibodies
How can you tell the difference between beta thalassemia trait and major
Major = symptomatic and young and significant anameia
Trait = microcytic but mild anaemia so not v symptoamtic
What can infleunce type 1 and type 2 errors?
Type 1 (likelihood of rejecting a true H0) = low p-value
Type 2 (likelihood of accepting a false H0) = higher power
What is Hawthorne effect
Group changing behaviour cos they know they are being studied
Difference between Phase I,II, III, IV cliniucal trials
I = very small human trials often healthy - check side effects
II = efficancy and dosing regimes in people who have the disease
III = pre-market approval, multi-centre and establishes effectiveness vs current regimes
IV = long-term effects post market licenseing